Add to ORKG© 2016 Informa UK Limited, trading as Taylor & Francis Group.Content: Identification of panel of SEREX-defined antigens for breast cancer autoantibodies profile detection. Objective: To create panel of antigens that can differentiate breast cancer patients and healthy individuals. Methods: SEREX (serological analysis of cDNA expression libraries) method, ELISA (enzyme-linked immunosorbent assay), qPCR (quantitative polymerase chain reaction). Results: In large-scale screening of 16 SEREX-antigens by sera of breast cancer patients and healthy donors, a combination of six antigens (RAD50, PARD3, SPP1, SAP30BP, NY-BR-62 and NY-CO-58) was identified, which can differentiate breast cancer patients and healthy donors with 70% sensitivity and 91% ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
To determine whether a panel of multiple tumor-associated antigens (TAAs) would enhance antibody det...
2-6 juin 2014International audienceBreast cancer is one of the most challenging diseases, endangerin...
© 2016 Informa UK Limited, trading as Taylor & Francis Group.Content: Identification of panel of SER...
Background: Tumor-associated antigens recognized by humoral effectors of the immune system are a ver...
© 2016 Lada Dyachenko et al.Purpose. To investigate a frequency of antibody response to SEREX-identi...
Mammography is essential to identify early breast cancer but the sensitivity is dependent on breast ...
Copyright © Experimental Oncology, 2015. Background: Colorectal, lung and breast tumors are the most...
There is an urgent need to identify relevant tumor markers showing high sensitivity and specificity ...
Serological analysis of recombinant complementary deoxyribonucleic acid (cDNA) expression libraries ...
We aimed to evaluate the immunodiagnostic values of autoantibodies to a panel of six tumor-associate...
ABSTR ACT: In order to develop a new tool for diagnosis of breast cancer based on autoantibodies aga...
Lung cancer is the second most frequent malignancy and the leading cause of cancer-associated death ...
SEREX (serological analysis of recombinant cDNA expression libraries) is a powerful approach to iden...
There is strong preclinical evidence that cancer, including breast cancer, undergoes immune surveill...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
To determine whether a panel of multiple tumor-associated antigens (TAAs) would enhance antibody det...
2-6 juin 2014International audienceBreast cancer is one of the most challenging diseases, endangerin...
© 2016 Informa UK Limited, trading as Taylor & Francis Group.Content: Identification of panel of SER...
Background: Tumor-associated antigens recognized by humoral effectors of the immune system are a ver...
© 2016 Lada Dyachenko et al.Purpose. To investigate a frequency of antibody response to SEREX-identi...
Mammography is essential to identify early breast cancer but the sensitivity is dependent on breast ...
Copyright © Experimental Oncology, 2015. Background: Colorectal, lung and breast tumors are the most...
There is an urgent need to identify relevant tumor markers showing high sensitivity and specificity ...
Serological analysis of recombinant complementary deoxyribonucleic acid (cDNA) expression libraries ...
We aimed to evaluate the immunodiagnostic values of autoantibodies to a panel of six tumor-associate...
ABSTR ACT: In order to develop a new tool for diagnosis of breast cancer based on autoantibodies aga...
Lung cancer is the second most frequent malignancy and the leading cause of cancer-associated death ...
SEREX (serological analysis of recombinant cDNA expression libraries) is a powerful approach to iden...
There is strong preclinical evidence that cancer, including breast cancer, undergoes immune surveill...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
To determine whether a panel of multiple tumor-associated antigens (TAAs) would enhance antibody det...
2-6 juin 2014International audienceBreast cancer is one of the most challenging diseases, endangerin...